Scancell (LON:SCLP) Announces Earnings Results

Scancell (LON:SCLP) released its quarterly earnings data on Thursday. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Scancell Stock Performance

LON SCLP traded up GBX 0.49 ($0.01) on Thursday, reaching GBX 10.15 ($0.13). The stock had a trading volume of 1,801,650 shares, compared to its average volume of 1,452,760. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 3.42. The stock has a market cap of £94.35 million, a P/E ratio of -1,015.00 and a beta of 0.35. The business’s 50-day moving average price is GBX 11.02 and its 200 day moving average price is GBX 13.67. Scancell has a 12-month low of GBX 8.60 ($0.11) and a 12-month high of GBX 19.75 ($0.25).

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.